the Activating Consciousness Technique (Hypnosis) in General Practice
NCT ID: NCT04649762
Last Updated: 2020-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2020-10-01
2022-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
On the other hand, it becomes embarrassing when it becomes uncontrollable. It can even lead to interfere with activities of daily living. Thus, we can speak of anxiety disorder.
Anxiety disorders are among the most prevalent psychiatric disorders. They are often associated with other comorbidities such as depression, which makes them more difficult to treat and diagnose.
Different treatments are offered to best treat the patient with anxiety : drug treatment (antidepressants, anxiolytics) ; non-drug (psychotherapy, meditation, cognitive behavioral therapies).
The emergence of hypnosis in medical practice in recent years seems to be a technique that can bring benefits to the patient.
A review of clinical studies does not seem to find a benefit to hypnosis in anxiety disorders. In contrast, a study in children with school phobia showed the effectiveness of hypnosis. The limits addressed by this review seem to relate to the number of people included in the studies. Contrariwise, it has been pointed out that hypnosis can have a beneficial effect in the long term.
Thus, it seems interesting to deepen this technique in the practice of a general practitioner exercising the activating consciousness technique in anxiety.
The study will be composed of patients presenting with anxiety and consulting their general practitioner, with: Group 1, patients consulting a doctor not practicing hypnosis Versus Group 2, patients consulting a doctor practicing hypnosis.
During the first consultation and the following 2 consultations scheduled by the general practitioner (spaced 15 days apart), the following data are noted, in addition to the monitoring usually performed by the doctor:
1. COVI scale
2. Comfort scale 0 to 10
3. Management: drugs, TAC, others
4. Quality of life survey SF36 Patients will be called back at 6 months to reassess quality of life (self-administered survey SF 36) The primary endpoint is to evaluated the change of anxiety from inclusion (J0) to 6 months using COVI scale in the two different groups.
For secondary endpoints, the consumption of drug medicine will be quantified and the quality of life will be measured using Quality of life survey SF36.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Group 1 includes patients with anxiety consulting a doctor not practicing hypnosis
No interventions assigned to this group
TAC
Group 2 includes patients with anxiety consulting a doctor practicing hypnosis
activating consciousness technique (hypnosis)
activating consciousness technique (hypnosis)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
activating consciousness technique (hypnosis)
activating consciousness technique (hypnosis)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Anxiety patient
* Patient who can return for consultation regularly and can be reached by phone
* Patient Not Opposing Participation In Study
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr Stéphane FOLACHER
Bourg-en-Bresse, , France
Dr Céline HUMBERT
Lyon, , France
Dr Matthieu DEMOURGUES
Lyon, , France
Dr Christian SAINT-CYR
Saint-Étienne-du-Bois, , France
Dr Aurélien BARADEL
Saint-Martin-du-Frêne, , France
Dr Maud BINARD
Villereversure, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Stéphane FOLACHER, MD
Role: primary
Céline HUMBERT, MD
Role: primary
Matthieu DEMOURGUES, MD
Role: primary
Christian SAINT-CYR, MD
Role: primary
Auurélien BARADEL, MD
Role: primary
Maud BINARD, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Pelissolo A. [Hypnosis for anxiety and phobic disorders: A review of clinical studies]. Presse Med. 2016 Mar;45(3):284-90. doi: 10.1016/j.lpm.2015.12.002. Epub 2016 Mar 2. French.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL20_0202
Identifier Type: -
Identifier Source: org_study_id